Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
84.19
-4.82 (-5.42%)
At close: Dec 12, 2025, 4:00 PM EST
84.19
0.00 (0.00%)
After-hours: Dec 12, 2025, 4:00 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $654.52 million as of December 12, 2025. Its market cap has increased by 13,012.27% in one year.
Market Cap
654.52M
Enterprise Value
617.34M
1-Year Change
13,012.27%
Ranking
Category
Stock Price
$84.19
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $654.52M, an increase of 1,466.46%. That is a compound annual growth rate of 76.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 693.39M | 176.65% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | 41.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |